Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Health Catalyst (HCAT) Return on Sales (2018 - 2025)

Historic Return on Sales for Health Catalyst (HCAT) over the last 8 years, with Q3 2025 value amounting to 0.29%.

  • Health Catalyst's Return on Sales fell 1000.0% to 0.29% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.34%, marking a year-over-year decrease of 800.0%. This contributed to the annual value of 0.23% for FY2024, which is 1700.0% up from last year.
  • Health Catalyst's Return on Sales amounted to 0.29% in Q3 2025, which was down 1000.0% from 0.51% recorded in Q2 2025.
  • Over the past 5 years, Health Catalyst's Return on Sales peaked at 0.18% during Q2 2024, and registered a low of 0.76% during Q4 2021.
  • Moreover, its 5-year median value for Return on Sales was 0.45% (2023), whereas its average is 0.43%.
  • In the last 5 years, Health Catalyst's Return on Sales soared by 3700bps in 2023 and then tumbled by -3300bps in 2025.
  • Over the past 5 years, Health Catalyst's Return on Sales (Quarter) stood at 0.76% in 2021, then surged by 32bps to 0.52% in 2022, then increased by 22bps to 0.4% in 2023, then soared by 36bps to 0.26% in 2024, then fell by -12bps to 0.29% in 2025.
  • Its Return on Sales was 0.29% in Q3 2025, compared to 0.51% in Q2 2025 and 0.3% in Q1 2025.